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ABSTRACT: The hypoglycemic effect of the ethanolic extract of Momordica charantia 
(cucurbitaceae) was investigated in both normal and streptozotocin – induced diabetic mice.  
The ethanolic extract of Unriped fruits of M. charantia (800mg/kg) reduced the blood glucose of 
normal mice from 172 ±3 to 136 ± 5 mg/100ml 4 hours after intrapertitoneal administration 
(P<0.001), and also significantly lowered the blood glucose of streptoxotocin induced diabetic 
mice from 686± 60 to 407± 35 mg/100ml under similar conditions (p<0.01).  The possible 
mechanism of hypoglycemic action of M.Charantia is due to the increased glucose uptake in 
liver cells because it markedly lowers the blood glucose levels in streptozotocin induced diabetic 
mice. 
 
INTRODUCTION  
 
The fruits, leaves and roots of Momordica 
charantia (cucubitaceae) have been used as 
a folk remedy for diabetes mellitus1. the 
fruits and leaves of the plant contain 
momordicine, a glucoside, a saponin like 
substance and an anthelmintic principle(2-
4).  There is an experimental evidence for 
the hypoglycemic action of these materials, 
the purpose of these study was to examine 
the hypoglycemic effect of M.Charantia 
(MC) unripe fruits. 
 
Materials and Methods 
 
The unriped fruits of M. Charantia were 
collected in the month of August, shade 
dried and pulverized.  The powder was 
passed through no 40 mesh.  The ethnolic 
extract of the powder was obtained by 
continuous soxhlet extraction, the extract 
was evaporated to dryness. It was dissolved 
in propylene glycol and used for 
experiments. 
 
Animals  
 
Swiss albino mice (20-24gms) were used 
throughout the study. They were housed in 
an air conditioned room at 22 ± 2
oC. The 
animals were kept in the experimental 
animal room for 7 days with free access to 
food and water. For the determination of 
blood glucose levels, blood samples were 
withdrawn by cardiac puncture. 
 
The animals were divided into two groups. 
One group was injected intravenously with 
150mg/kg body weight of streptozotocin 
(STZ) freshly dissolved in citrate buffer (pH 
4.5) and the other group was administered 
buffer alone and used as a control. Eight 
days after injection of STZ, the blood 
glucose levels of all the mice were 
determined. Mice with a blood glucose level 
above 300mg/100ml were considered to be 
diabetic and were used in the study. The 
hypoglycemic effect of ethanolic extract of 
M. charantia were compared with that of 
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Tolbutamide in  normal and STZ- induced 
diabetic mice respectively. Five to six 
animals were used for each group. 
 
Determination of blood glucose 
 
Blood glucose levels in both normal and 
diabetic animals were determined by the 
glucose oxidase method
5.  All the data were 
expressed as means ± SEM and student “t” 
test was used for the analysis
6. 
 
Results and discussion  
 
The mean blood glucose levels of mice at 
various time intervals after i.p. 
administration of M. Charantia are shown in 
table-I these levels were compared with the 
values in control mice administered saline 
along and also with those in animals 
receiving 50mg/kg body weight of 
tolbutamide.  The hypoglycemic effect of M. 
charantia was dose dependent. MC at dose 
level of 200 and 400 mg/kg altered blood 
glucose significantly, while MC at 
800mg/kg lowered blood glucose form the 
basal value of 172 ± 3 mg/100ml to 136 ± 
5mg/100ml (P<0.001), 4 hours after the 
administration . 
 
The hypoglycemic effects of MC and insulin 
on the blood glucose of streptozotocin – 
induced diabetic mice are shown in table II. 
No differences in blood glucose were 
observed between the levels at times 2,4,7 
and 10 hours after the administration when 
compared with the basal values in control 
mice.  However, MC at 200,400 and 
800mg/kg treated mice showed a significant 
decrease in blood glucose after 4 hours 
when compared with the basal values.  (MC 
200,800: P<0.01, MC 400; P<0.001).  The 
hypoglycemic effect of MC in STZ mice 
also was dose-dependent, Insulin treated 
mice (5U/kg body weight) exhibited a 
significant decrease in the blood glucose at 2 
hours, when compared with the basal values 
(P<0.001). 
 
The present study clearly shows that the 
ethanolic extract of the unripe fruits of 
Momordica charantia (MC) produces 
significant hypoglycemic effects in normal 
mice. In addition. We have examined the 
therapeutic effect of MC on hyperglycemia 
in STZ induced diabetes. In mice.  The 
probable mechanism, may be increased 
glucose uptake by the liver cell, because MC 
markedly lowers blod glycose levels in STZ 
induced diabetic mice. 
 
Table -1 
Effect of Momordica charantia on blood glucose in normal mice 
 
Blood glucose (mg/100ml)   
  0hr 2hr  4hr 7hr  10hr 
Control  176 ± 8  177 ± 5  172 ± 8  174 ± 4  183±6 
MC 200mg/kg  179 ± 6  183 ± 3  160 ± 8*  159 ±10  163±8 
MC 400mg/kg  175 ± 5  182 ± 7  133± 6*** 137 ± 8**  137±7*** 
MC 800mg/kg  172 ± 3  181 ± 3  141 ± 8**  141 ± 8**  147±5** 
Tolbutamide 50mg/kg  190 ± 4  120± 2***  140 ± 8**  140 ± 8**  156±3*** 
                                         *P<0.05      **P<0.01        ***P<.001 
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Table -1I 
Effect of Momordica charantia on blood glucose in normal mice 
 
Blood glucose (mg/100ml)   
  0hr 2hr  4hr 7hr  10hr 
Control  596 ±67  583±90  567 ±64  517±36  617±60 
MC 200mg/kg  656 ±17  544±19**  522±31*  553±39*  586±33 
MC 400mg/kg  635±42  457±22**  418±26*** 513± 43  582±33 
MC 800mg/kg  686±60  423±29**  470±35  478± 48*  587±49 
Tolbutamide 50mg/kg  586±31  304±36***  545±47  523±47  579±40 
                                         *P<0.05      **P<0.01        ***P<.001 
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